Jakub Závada

4.3k total citations
59 papers, 1.2k citations indexed

About

Jakub Závada is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Jakub Závada has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 17 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Jakub Závada's work include Rheumatoid Arthritis Research and Therapies (21 papers), Spondyloarthritis Studies and Treatments (11 papers) and Systemic Lupus Erythematosus Research (10 papers). Jakub Závada is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (21 papers), Spondyloarthritis Studies and Treatments (11 papers) and Systemic Lupus Erythematosus Research (10 papers). Jakub Závada collaborates with scholars based in Czechia, Netherlands and Slovenia. Jakub Závada's co-authors include Karel Pavelká, Jiří Vencovský, H. Mann, Rodrigo Cartin‐Ceba, Rinaldo Bellomo, Ognjen Gajić, Vladimı́r Tesař, Gilles Clermont, John A. Kellum and Eric A. J. Hoste and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Frontiers in Immunology.

In The Last Decade

Jakub Závada

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jakub Závada Czechia	19	481	322	306	242	173	59	1.2k
Eric Wallace United States	23	176 0.4×	404 1.3×	65 0.2×	169 0.7×	284 1.6×	83	1.6k
S Vasoo Singapore	15	313 0.7×	78 0.2×	239 0.8×	143 0.6×	101 0.6×	29	915
Grace S. Park United States	19	860 1.8×	82 0.3×	409 1.3×	138 0.6×	91 0.5×	31	1.4k
Arijit Ganguli United States	22	439 0.9×	65 0.2×	360 1.2×	66 0.3×	187 1.1×	90	1.4k
Richard Brasington United States	22	868 1.8×	138 0.4×	338 1.1×	158 0.7×	125 0.7×	41	1.7k
Y. Benhamou France	22	348 0.7×	415 1.3×	671 2.2×	103 0.4×	182 1.1×	123	1.8k
F Mignon France	22	402 0.8×	814 2.5×	289 0.9×	333 1.4×	108 0.6×	70	1.9k
Alí Duarte‐García United States	20	844 1.8×	99 0.3×	355 1.2×	86 0.4×	40 0.2×	71	1.2k
Alfred Cividino Canada	19	833 1.7×	62 0.2×	231 0.8×	157 0.6×	112 0.6×	33	1.5k
Paras Karmacharya United States	22	454 0.9×	66 0.2×	317 1.0×	85 0.4×	100 0.6×	81	1.3k

Countries citing papers authored by Jakub Závada

Since Specialization

Citations

This map shows the geographic impact of Jakub Závada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Závada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Závada more than expected).

Fields of papers citing papers by Jakub Závada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Závada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Závada. The network helps show where Jakub Závada may publish in the future.

Co-authorship network of co-authors of Jakub Závada

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Závada. A scholar is included among the top collaborators of Jakub Závada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Závada. Jakub Závada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Georgiadis, Stylianos, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, et al.. (2024). Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?. The Journal of Rheumatology. 51(7). 673–677. 1 indexed citations

Vencovský, Jiří, et al.. (2024). Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry. Scandinavian Journal of Rheumatology. 54(2). 79–86.

Friedecký, David, Radana Brumarová, Markéta Pavlı́ková, et al.. (2023). Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment. Arthritis Research & Therapy. 25(1). 234–234. 22 indexed citations

Cerezo, Lucie Andrés, Hana Hulejová, Markéta Pavlı́ková, et al.. (2023). Interleukin-37: associations of plasma levels and genetic variants in gout. Arthritis Research & Therapy. 25(1). 203–203. 2 indexed citations

Mann, H., et al.. (2022). The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry. Rheumatology International. 42(5). 803–814. 7 indexed citations

Cerezo, Lucie Andrés, Hana Hulejová, Michal Tomčík, et al.. (2021). IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis. Frontiers in Immunology. 12. 745523–745523. 25 indexed citations

Rupel, Valentina Prevolnik, Zsombor Zrubka, Fanni Rencz, et al.. (2019). EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review. The European Journal of Health Economics. 20(S1). 109–117. 10 indexed citations

Závada, Jakub, Michal Svoboda, Michal Uher, et al.. (2019). Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry. Expert Opinion on Biological Therapy. 20(2). 183–192. 6 indexed citations

Pavlı́ková, Markéta, Hana Hulejová, Petr Kozlík, et al.. (2019). Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors. Rheumatology International. 39(10). 1749–1757. 16 indexed citations

10.

Lee, Anne, Marie Skougaard, Jakub Závada, et al.. (2018). The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different Methodologies. JMIR Research Protocols. 7(7). e165–e165. 18 indexed citations

11.

Hulejová, Hana, Jakub Závada, Martin Komarc, et al.. (2018). Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. Clinical Rheumatology. 37(8). 2055–2062. 27 indexed citations

12.

Stibůrková, Blanka, Kateřina Pavelcová, Jakub Závada, et al.. (2017). Functional non-synonymous variants of ABCG2 and gout risk. Lara D. Veeken. 56(11). 1982–1992. 63 indexed citations

13.

Hulejová, Hana, Jakub Závada, Petra Hánová, et al.. (2017). Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study. PLoS ONE. 12(8). e0183420–e0183420. 28 indexed citations

14.

Závada, Jakub, Petra Hánová, Michal Uher, et al.. (2017). The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis – a cohort study. Arthritis Research & Therapy. 19(1). 5–5. 15 indexed citations

15.

Zrubka, Zsombor, Fanni Rencz, Jakub Závada, et al.. (2017). EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis. Rheumatology International. 37(12). 1957–1977. 10 indexed citations

16.

Hulejová, Hana, Jakub Závada, Martin Komarc, et al.. (2016). Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission. PLoS ONE. 11(11). e0165498–e0165498. 14 indexed citations

17.

Rencz, Fanni, László Gulàcsi, Michael Drummond, et al.. (2016). EQ-5D in Central and Eastern Europe: 2000–2015. Quality of Life Research. 25(11). 2693–2710. 118 indexed citations

18.

Závada, Jakub, Petra Hánová, Hana Hulejová, et al.. (2015). Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 252–252. 52 indexed citations

19.

Tegzová, Dana, Jakub Závada, Marta Olejarová, et al.. (2013). FRI0262 Differences in serum microrna profile in active systemic lupus erythematosus and healthy controls. Annals of the Rheumatic Diseases. 72. A463–A463. 1 indexed citations

20.

Závada, Jakub, et al.. (2008). Circulating Endothelial Cells and Circulating Endothelial Progenitors in Kidney Disease – Victims, Witnesses, or Accomplices?. Folia Biologica. 54(3). 73–80. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact